← Open Payments lookup

MANUEL SKOW: Open Payments

NPI 1083888481 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,551 in 118 payments from 27 companies in 2025. Trend: 2023 $2,535 · 2024 $2,308 · 2025 $2,551

Food & beverage: $2,551
CompanyPaymentsAmount
Novo Nordisk Inc21$498
Lilly USA, LLC13$274
Dexcom, Inc.7$213
ABBVIE INC.9$172
Boehringer Ingelheim Pharmaceuticals, Inc.7$159
PFIZER INC.9$156
AstraZeneca Pharmaceuticals LP6$128
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$124
Exact Sciences Corporation4$79
Bayer Healthcare Pharmaceuticals Inc.4$78

Products named: MOUNJARO, Rybelsus, JARDIANCE, Ozempic, XIFAXAN, Dexcom G6 Transmitter, VRAYLAR, Wegovy.

Industry payments across MD — which companies pay providers there.